We demonstrate that LASP1 is specifically phosphorylated by BCR-ABL at tyrosine-171 in CML patients, which is abolished by tyrosine kinase inhibitor therapy. The gene discussed is LASP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.